Brief: Nektar Therapeutics Announces Pricing Of Upsized $325 Million Public Offering
22/04/2026 02:31
April 21 (Reuters) - Nektar Therapeutics NKTR.O: NEKTAR THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $325 MILLION PUBLIC OFFERING NEKTAR THERAPEUTICS - SELLS 3,532,609 SHARES AT $92.00 PER SHARE Source text: ID:nPn9SBGHva Further company coverage: NKTR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nektar Therapeutics
See all newsBrief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio
U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says